BiomX Inc.(PHGE)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

BiomX Inc. (PHGE) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PHGE at 29.4/100 on a 32-signal composite quality model, placing it at rank #2,468 of 2,884 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (0.6) and revenue growth (30.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 30.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), BiomX Inc. reports quarterly revenue of $332.0K, net income of $-3.8M. Top institutional holders of PHGE by reported 13-F value include Nantahala Capital Management, COMMONWEALTH EQUITY SERVICES, Ikarian Capital, based on the most recent SEC filings. PHGE trades on the NYSE exchange and files with the SEC under CIK 1739174. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PHGE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BiomX Inc. directly from SEC EDGAR.